5 ASX dividend shares to buy in January

With the new year underway, many investors are turning their attention back to income opportunities on the Australian share market.

While interest rates may eventually rise, quality dividend shares continue to offer the potential for reliable income alongside long-term capital growth.

For investors looking to put money to work this January, here are five ASX dividend shares that stand out for their cash-generating ability and long-term relevance.

Accent Group Ltd (ASX: AX1)

Accent Group operates a portfolio of leading footwear and apparel brands, including Platypus, Skechers, and The Athlete's Foot.

While consumer spending has been under pressure, Accent's focus on vertically integrated retailing, private-label growth, and disciplined cost control has allowed it to keep paying dividends through a tough cycle. And with its shares down heavily over the last 12 months, now could be an opportune time for patient investors to snap them up.

Harvey Norman Holdings Ltd (ASX: HVN)

Harvey Norman is a well-known name among income investors, thanks to its long history of dividend payments and asset-backed balance sheet. The retailer benefits from a large property portfolio, offshore operations, and exposure to housing-related spending.

While its earnings can be cyclical, Harvey Norman's conservative capital management and strong cash position have supported regular dividends over many years. That combination could make it an attractive option for income investors seeking some downside protection.

HomeCo Daily Needs REIT (ASX: HDN)

A third ASX dividend share that could be a buy for income investors is HomeCo Daily Needs REIT. It owns convenience-based retail assets focused on everyday services such as supermarkets, healthcare, and essential retail. These properties tend to generate stable rental income, supported by long leases and defensive tenants.

Because its portfolio is designed around non-discretionary spending, HomeCo has been able to deliver attractive distributions even during periods of economic uncertainty. For income portfolios, this kind of predictability can be very appealing.

Sonic Healthcare Ltd (ASX: SHL)

Sonic Healthcare is one of the world's largest pathology and diagnostic imaging providers, with operations across Australia, Europe, and the United States.

While its performance since the pandemic has been underwhelming, there are signs that the company is now in a position to deliver consistent and solid earnings growth over the coming years. This could make it a good pick for income investors, especially given how healthcare demand is inherently defensive.

Transurban Group (ASX: TCL)

Finally, Transurban could be an ASX dividend share to buy. It owns and operates toll roads across Australia and North America, generating growing cash flows from essential transport infrastructure. Its assets benefit from long concession lives, inflation, population growth, and rising traffic volumes over time.

It is no surprise that Transurban's ability to deliver predictable distributions underpinned by contracted revenue makes it a cornerstone holding in many dividend-focused portfolios.

The post 5 ASX dividend shares to buy in January appeared first on The Motley Fool Australia.

Motley Fool contributor James Mickleboro has positions in Accent Group. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Transurban Group. The Motley Fool Australia has positions in and has recommended Harvey Norman and Transurban Group. The Motley Fool Australia has recommended Accent Group, HomeCo Daily Needs REIT, and Sonic Healthcare. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Motley Fool's purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool's free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson. 2026